Urethral toxicity after LDR brachytherapy: Experience in Japan
Author:
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology
Reference16 articles.
1. Saito S, Ito K, Yorozu A, et al. Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS). Int J Clin Oncol. 2014 May 21. [Epub ahead of print].
2. Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?;DA;Int J Radiat Oncol Biol Phys,2011
3. Contemporary evaluation of the National Comprehensive Cancer Network prostate cancer risk classification system;Reese;Urology,2012
4. 25-Year disease-free survival rate after irradiation for prostate cancer calculated with the prostate specific antigen definition of recurrence used for radical prostatectomy;FA;J Urol,2013
5. The biochemical recurrence-free rate in patients who underwent prostate low-dose-rate brachytherapy, using two different definitions;Tanaka;Radiat Oncol,2014
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Duration of α-1 adrenergic antagonist administration after low-dose-rate brachytherapy for prostate cancer;Japanese Journal of Clinical Oncology;2024-08-28
2. Validation of the bladder neck as an important organ at risk in prostate seed brachytherapy based on D2cc: A single-institution, retrospective review;Journal of Contemporary Brachytherapy;2023
3. Acute and late side-effects after low dose-rate brachytherapy for prostate cancer; incidence, management and technical considerations;Brachytherapy;2021-09
4. A prospective study of oral 5-aminolevulinic acid to prevent adverse events in patients with localized prostate cancer undergoing low-dose-rate brachytherapy: Protocol of the AMBER study;Contemporary Clinical Trials Communications;2020-09
5. First-passage times and normal tissue complication probabilities in the limit of large populations;Scientific Reports;2020-05-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3